Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colonic Neoplasms × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Melanoma 2 Kidney Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma 2 Advanced Solid Tumors 2 Uterine Cervical Neoplasms 1 Solid Malignancies 1 Small Cell Lung Carcinoma 1 Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1 Ovarian Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Kidney Diseases 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1

Interventions

Oxaliplatin 31 Fluorouracil 31 Leucovorin 29 Irinotecan 23 Cetuximab 20 Bevacizumab 16 Capecitabine 13 Gemcitabine 10 pembrolizumab 8 Folfox protocol 7 Carboplatin 7 Paclitaxel 6 Nivolumab 6 Cyclophosphamide 6 Cisplatin 6 trifluridine tipiracil drug combination 5 cediranib 5 Erlotinib Hydrochloride 5 adagrasib 4 Ipilimumab 4 IFL protocol 4 Floxuridine 4 Bortezomib 4 veliparib 3 trametinib 3 sargramostim 3 poly ICLC 3 binimetinib 3 Trifluridine 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04873895 2024-04-26

TACE-Ax-HCQ

Abramson Cancer Center at Penn Medicine

Phase 1 Terminated

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡